Percutaneous Coronary Intervention in Transcatheter Aortic Valve Implantation Patients: Overview and Practical Management

Coronary artery disease (CAD) is present in 40–75% of patients undergoing transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis. Currently, the indication for TAVI is expanding toward younger patients at lower surgical risk. Given the progressive nature of CAD, the ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Weferling, Maren, Hamm, Christian W., Kim, Won-Keun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129193/
https://www.ncbi.nlm.nih.gov/pubmed/34017866
http://dx.doi.org/10.3389/fcvm.2021.653768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129193/
https://www.ncbi.nlm.nih.gov/pubmed/34017866
http://dx.doi.org/10.3389/fcvm.2021.653768

Ejemplares similares